Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters.
about
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation.Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization.Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis.Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken designNanoprecipitation of polymeric nanoparticle micelles based on 2-methacryloyloxyethyl phosphorylcholine (MPC) with 2-(diisopropylamino)ethyl methacrylate (DPA), for intracellular delivery applications.Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriersFormulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken designFormulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention.Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery.Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.Lipid nanoparticles for the delivery of poorly water-soluble drugs.Statins therapy: a review on conventional and novel formulation approaches.Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.Lipid-based carriers: manufacturing and applications for pulmonary route.Nanostructured lipid carriers system: recent advances in drug delivery.Solid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.Nanostructured lipid carriers and their current application in targeted drug delivery.Lipid nanoparticles for the topical delivery of retinoids and derivatives.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate.Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent.Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery.Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique.Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.Manufacture of liposomes by isopropanol injection: characterization of the method.Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery.Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design.Solid lipid nanoparticles produced through a coacervation method.Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles.SLN and NLC for topical delivery of ketoconazole.
P2860
Q30366990-8A46D46A-3E21-41BC-9452-6E58A961352FQ30379795-360F6806-8F75-4FB5-B36F-D9CB93DBDC73Q30390764-7E92B6CF-E64D-4459-8822-363B506A117CQ31151834-23C11DDE-A4BD-46EC-8482-4D73D7BF23FBQ33251072-BC1F9B32-98F4-41D8-90A6-65A4EE19B8F5Q33986062-6E94AD37-D1AE-4F84-9810-062CAFF0EDC9Q34160297-DAE97677-4CFB-42F1-9E54-18D883C1D757Q34733880-8E821121-07C1-422C-BFA8-F4262C3A204FQ34883416-5757750B-9B42-4AD5-9E93-85DC998C78B6Q35577671-69DF3215-2420-4ADB-B1E6-31B192F9A936Q35596460-9A60B673-9421-40D1-9249-F8E6BAC34312Q35796474-48E4ABB5-7A79-4FBC-A7DD-1AD7FDCA5952Q36032471-FF8D97F7-79FC-436B-B464-0E49E7FAAC78Q36452190-31B6715B-4B0A-496A-861F-D2151EC225D2Q37004099-2933B5CC-9DA0-4B44-BADC-5F1C627B04F1Q37805594-08A6AAD1-2BB2-4FCA-8106-819507DD31CBQ37896125-1381856E-FF9B-4EB5-8BF0-695053A88F29Q37996097-71E468D9-9C25-4B2D-AE8F-075C10B00FF0Q38020888-0B915ABB-0FD4-45BE-AEFF-2E451F0FC0F3Q38038902-7337C852-1485-452B-9B33-4220C5FCBAEEQ38160303-97F515CA-8F69-4A2A-91B2-E4ED572DA121Q38199540-11CAA7BF-3013-4E44-9D98-9D01FAAE0B22Q38210565-5B27CE28-AEA6-488B-B2D8-A60E74B6AEC6Q38324016-EE530917-03B2-41A4-856D-DD5FD5CDEEE1Q38558905-C67BF288-7F8E-4B32-9F23-3DB2D4C7F7C8Q39096524-4651AC5B-6F21-4488-A1AC-E8CE5AC0B94EQ39130500-A5E3B89E-3BA0-42A1-950A-66F380AA86D5Q39285717-23CF50DF-B800-4DC2-870C-DB24B6B72FEAQ39369529-46AAF73B-85F4-4198-9144-589642B0630EQ39518686-E38EF813-2610-4B52-AC17-19D7C13090F8Q39810160-0F41383E-328A-40C5-AB33-5DE3D9027392Q41615502-98F2C7A1-328D-47BE-B8B3-06E8977A45E2Q42722291-3B3DB691-E505-4CF0-AD3E-470CACC0D697Q43235591-A4B17FAA-00B0-456D-94B3-6FFEDD8AA3CBQ43245706-C82F4CDA-675F-4474-B4CE-EB759A4375E7Q45954910-15EC3754-9902-42E5-B9A5-DB877B87E1BBQ45963399-6E16E21C-9E91-4189-8D39-D364F63F6E6EQ46135315-DEE15F38-C379-48FA-9D2B-8ABA4B47D06AQ46558378-E92FB2EA-CAE9-4773-A1EB-32C943EFFEE8Q46856307-E57556E6-B5F1-4815-9D74-0FC2287A8DEC
P2860
Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Solvent injection as a new app ...... method and process parameters.
@en
Solvent injection as a new app ...... method and process parameters.
@nl
type
label
Solvent injection as a new app ...... method and process parameters.
@en
Solvent injection as a new app ...... method and process parameters.
@nl
prefLabel
Solvent injection as a new app ...... method and process parameters.
@en
Solvent injection as a new app ...... method and process parameters.
@nl
P1476
Solvent injection as a new app ...... method and process parameters.
@en
P2093
Müller-Goymann CC
Schubert MA
P304
P356
10.1016/S0939-6411(02)00130-3
P407
P577
2003-01-01T00:00:00Z